BRIEF published on 09/19/2025 at 18:05, 9 months 24 days ago Advicenne : Résultats semestriels en 2025 et perspectives Chiffre D'affaires Résultats Financiers Perspectives États-Unis Sibnayal®
PRESS RELEASE published on 09/19/2025 at 18:00, 9 months 24 days ago Informations privilégiées / Communiqué sur comptes, résultats Advicenne présente ses résultats financiers semestriels au 30 juin 2025 et fait le point sur ses activités. Augmentation du chiffre d'affaires et perspectives favorables avec Sibnayal® Résultats Financiers Croissance Perspectives Advicenne Sibnayal®
BRIEF published on 07/28/2025 at 07:35, 11 months 16 days ago Advicenne obtient l'autorisation de mise sur le marché de Sibnayal® en Arabie saoudite Arabie Saoudite Remboursement Advicenne ATRd Sibnayal®
BRIEF published on 07/28/2025 at 07:35, 11 months 16 days ago Advicenne Secures Marketing Authorization for Sibnayal® in Saudi Arabia Saudi Arabia Advicenne Reimbursement Sibnayal® DRTA
PRESS RELEASE published on 07/28/2025 at 07:30, 11 months 16 days ago Informations privilégiées / Autres communiqués Advicenne obtient l’AMM et le remboursement de Sibnayal en Arabie Saoudite pour le traitement des maladies rénales rares. Collaboration avec Taïba Healthcare Arabie Saoudite Advicenne Maladies Rénales Rares AMM Sibnayal
PRESS RELEASE published on 07/28/2025 at 07:30, 11 months 16 days ago Inside Information / Other news releases Advicenne obtains marketing authorization and reimbursement for Sibnayal® in Saudi Arabia, a fixed combination for rare kidney diseases, in collaboration with Taïba Healthcare Saudi Arabia Advicenne Reimbursement Marketing Authorization Sibnayal
BRIEF published on 07/25/2025 at 07:35, 11 months 19 days ago Advicenne Annonce une Croissance de 9% de son Chiffre d'Affaires pour le S1 2025 Chiffre D'affaires Croissance Advicenne Sibnayal® Marchés Pharmaceutiques
BRIEF published on 07/25/2025 at 07:35, 11 months 19 days ago Advicenne Announces 9% Revenue Growth for H1 2025 Growth Turnover Advicenna Sibnayal® Pharmaceutical Markets
PRESS RELEASE published on 07/25/2025 at 07:30, 11 months 19 days ago Inside Information / Other news releases Advicenne reports H1 2025 sales of €2.6 million, with direct sales rising 17% and Sibnayal® sales in Europe up 90% compared to H1 2024. Company's cash flow horizon extends to Q3 2026 Cash Flow Pharmaceutical Advicenne Sibnayal H1 2025 Sales
PRESS RELEASE published on 07/25/2025 at 07:30, 11 months 19 days ago Informations privilégiées / Autres communiqués Advicenne publie un chiffre d'affaires en hausse de 9% au S1 2025, avec des ventes de Sibnayal® en progression de 17%. La société dispose de trésorerie jusqu'au 3ème trimestre 2026 Chiffre D'affaires Trésorerie Advicenne S1 2025 Sibnayal®
Published on 07/14/2026 at 01:45, 5 hours ago Arctic Fox Lithium Approved for Trading on the OTCQB Venture Market and Announces DTC Eligibility
Published on 07/14/2026 at 00:01, 6 hours 44 minutes ago Captor Capital Announces Delay in its Annual Filings
Published on 07/13/2026 at 23:10, 7 hours 35 minutes ago Galaxy Ventures Inc. Announces Director Resignation
Published on 07/13/2026 at 21:35, 9 hours 10 minutes ago ATHA Energy Announces Corporate Activities Update
Published on 07/13/2026 at 20:00, 10 hours 45 minutes ago IBC Announces Share-Based Compensation to Directors
Published on 07/14/2026 at 06:30, 15 minutes ago Formycon AG and OneSource Specialty Pharma announce strategic Manufacturing Partnership for Biosimilars
Published on 07/14/2026 at 04:45, 1 hour 59 minutes ago Asia’s Debut of LEAP East in HKCEC Marks Hong Kong’s Largest Inaugural Tech Summit
Published on 07/13/2026 at 22:30, 8 hours 14 minutes ago Half-year 2026 Results Media and Investor Conference Call and Webcast
Published on 07/13/2026 at 21:20, 9 hours 24 minutes ago Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 21:17, 9 hours 27 minutes ago EQS-Adhoc: Ad hoc: Evotec Announces Preliminary Second Quarter and First Half 2026 Results and Updates Full-Year 2026 Outlook
Published on 07/13/2026 at 18:00, 12 hours 45 minutes ago CP Icade - Icade reprend 100% de la propriété de la Tour Eqho à la Défense
Published on 07/13/2026 at 18:00, 12 hours 45 minutes ago PR Icade - Icade regains full ownership of the Eqho Tower in La Défense
Published on 07/13/2026 at 18:00, 12 hours 45 minutes ago THERMADOR GROUPE : publication du chiffre d'affaires semestriel 2026
